Published by Iain Gilbert on 26th October 2026
(Sharecast News) - Drugmaker GSK reported two sets of encouraging cancer‑drug results on Monday, with fresh data for its experimental ovarian‑cancer therapy Mo‑Rez and new interim findings for Jemperli in rectal cancer, both due to be presented at the ESMO Congress.
URL: http://www.digitallook.com/dl/news/story/36305113/...